| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (3MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-514645
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.51464
Zusammenfassung
Cold Atmospheric Plasma (CAP) has shown promising results in the treatment of various skin diseases. The therapeutic effect of CAP on localized scleroderma (LS), however, has not yet been evaluated. We investigated the effects of CAP on LS by comparing human normal fibroblasts (hNF), human TGF-beta-activated fibroblasts (hAF), and human localized scleroderma-derived fibroblasts (hLSF) after ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags